GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (XSWX:VRX) » Definitions » Cyclically Adjusted PS Ratio

Bausch Health (XSWX:VRX) Cyclically Adjusted PS Ratio : (As of May. 01, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Bausch Health Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bausch Health Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Bausch Health's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Cyclically Adjusted PS Ratio Chart

Bausch Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.51 0.94 1.10 0.24 0.28

Bausch Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 0.30 0.29 0.30 0.28

Competitive Comparison of Bausch Health's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bausch Health's Cyclically Adjusted PS Ratio falls into.



Bausch Health Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Bausch Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Bausch Health's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=5.859/125.4675*125.4675
=5.859

Current CPI (Dec. 2023) = 125.4675.

Bausch Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 4.959 98.604 6.310
201406 5.357 99.473 6.757
201409 5.645 99.394 7.126
201412 6.342 98.367 8.089
201503 6.192 99.789 7.785
201506 7.395 100.500 9.232
201509 7.721 100.421 9.647
201512 7.877 99.947 9.888
201603 6.747 101.054 8.377
201606 6.801 102.002 8.366
201609 6.903 101.765 8.511
201612 7.005 101.449 8.664
201703 6.026 102.634 7.367
201706 6.175 103.029 7.520
201709 6.062 103.345 7.360
201712 6.048 103.345 7.343
201803 5.393 105.004 6.444
201806 5.997 105.557 7.128
201809 5.884 105.636 6.989
201812 5.978 105.399 7.116
201903 5.742 106.979 6.734
201906 6.039 107.690 7.036
201909 6.210 107.611 7.240
201912 6.196 107.769 7.214
202003 5.462 107.927 6.350
202006 4.455 108.401 5.156
202009 5.467 108.164 6.342
202012 5.524 108.559 6.384
202103 5.303 110.298 6.032
202106 5.364 111.720 6.024
202109 5.481 112.905 6.091
202112 5.690 113.774 6.275
202203 5.015 117.646 5.348
202206 5.369 120.806 5.576
202209 5.603 120.648 5.827
202212 5.748 120.964 5.962
202303 5.062 122.702 5.176
202306 5.490 124.203 5.546
202309 5.665 125.230 5.676
202312 5.859 125.468 5.859

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bausch Health  (XSWX:VRX) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Bausch Health Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Bausch Health's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch Health (XSWX:VRX) Business Description

Traded in Other Exchanges
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health (XSWX:VRX) Headlines

No Headlines